Biobanking for Medicine: Technology, Industry and Market 2015-2025

Jul 07, 2015, 09:00 ET from Visiongain

LONDON, July 7, 2015 /PRNewswire/ --

Biobanks - How to Discover Trends, R&D and Sales Forecasts, Helping Your Influence 


Are you interested in the future of medical biobanking? If so, now gain technological and commercial predictions from 2015. You stay ahead for data, benefiting your authority. There explore trends in research and development, results, opportunities and revenue forecasts.

That new study by visiongain shows you what's possible for biobanking and associated technology to improve healthcare. Avoid missing out. Instead find sales prospects for that biomedical industry and market, discovering expected trends, progress and financial gains.

Biobank services and technology hold great influence on drug discovery and development. That importance increases from 2015. Discover why and how, seeing what's possible.

Potential of those biorepository technologies and facilities - explore what's happening
In medical research those biostorage systems form an important resource. They support fields including genomics and personalised medicine, letting companies harness samples.

Our report's purpose is showing you the commercial potential in storing human biological samples for use in research and therapies, including conserving stem cells.

Please read on, then, to explore those technologies and services for human medicine, finding what influences that market and its predicted results.

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

Forecasts and other information showing lucrative possibilities for biorepositories
That study gives sales predictions to 2025 at overall world, submarket and national level. You also get sample unit predictions. For biosample and biospecimen storage, especially for pharmaceutical R&D, you investigate where applications, needs, demand and money lie.

Why struggle to find information or miss data you need on medical biopreservation? Besides revenue forecasting, our new analysis shows you results, growth rates and market shares.

There you explore those technologies for medical R&D - especially applications suiting drug companies. You also discover 72 tables, 73 charts and two interviews with other authorities on that biosample preservation for analytical use.

Though no such study covers everything, the following sections explain how our new investigation benefits your work.

Forecasting of that world market and its segments - what's likely to happen?
What're the secrets of that biostorage progress? Discover in our report overall world revenue to 2025, with discussions, for storing human cell, tissue and fluid samples.

So help your research, analyses and decisions on storage of human biological samples (HBS). As someone with authority, benefit your reputation for technological and commercial insight.

Also find individual revenue predictions to 2025 for nine submarkets at world level:

• Biobanking for research
• Biobanking for therapeutic uses.

The survey also forecasts the number of samples stored in those two fields. And it gives biobanking revenue forecasting to 2025 by research application:

• Human tissues - also with sub-forecasts for public sector and commercial uses
• Stem cells
• Other biological sample banking applications - inc. DNA and body fluids.

And that analysis predicts stem cell banking revenues to 2025 for therapeutic uses:

• Umbilical cord stem cell banking
• Adult stem cell banking.

You also get forecasts to 2025 for the number of samples banked for research and therapeutic applications.

In our study you assess outlooks for sales expansion, hearing where you could gain. That work explores competition and demand, showing technological and commercial possibilities.

So hear what's happening. You also investigate geographical revenue potentials.

Biostorage needs in leading national markets - what outlooks for demand, sales and provision?
In developed and developing countries, opportunities for companies providing biorepository facilities, products, services, consumables and technology will expand from 2015. See where, exploring commercial gains possible.

Our analyses show you individual revenue forecasts to 2025 for 12 leading national biobanking markets:

The United States (US)
Japan
Germany, France, The UK, Italy, Spain (EU5 countries) and The Netherlands
Brazil, Russia, India and China (BRIC nations).

There discover countries with highest sales, demand and potential expansion of usage and revenues. That way you investigate progress, needs, opportunities and competitors. And you see the gains possible, finding how you could expand business.

Also what events, challenges and advances in technology affect biorepositories?

Forces influencing suppliers and users of those biomedical resources and libraries
Our new study explores issues, events and contributions affecting that industry and market from 2015, including these influences:

• Guidelines, research and medical ethics, standards (e.g. GLP), legislation, regulations and governmental funding for that biopreservation, inc. HIPAA amendments
• Systems for cryopreservation, biobank networks and biobanking infrastructure
• Facilities, freezers, operations software, consumables and services
• Biobanking in research, drug discovery and development, inc. biomarkers and personalised medicine
• Uses in therapeutics, clinical trials and genome-wide association studies (GWAS).

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

And you explore these forces, among others:

• Numbers and geographical distribution of biobanks
• Umbilical cord blood banking and induced pluripotent stem cells (iPSCs)
• RFID, tagging technology and laboratory information management systems (LIMS)
• Technologies and services aiding genetic epidemiology studies and understanding of disease pathways
• Automated liquid handling systems, aliquotting and automation in DNA isolation
• Biobanking services - sample storage, tracking, management and transport of human biological samples.

There discover what's happening to benefit human healthcare, also gaining feel for challenges, trends and outlooks.

That way you find what stimulates and restrains organisations performing and helping that biosample preservation, affecting their results and those of clients.

Technologies and applications for biobanks - top organisations and 2019 market value
What's possible? Our study predicts that overall world market will generate $25bn in 2019. Rising demand for biobanked samples for use by pharmaceutical companies in preclinical research most stimulates that market. So explore the high, rising revenues possible to 2025.

And our analysis shows activities of biobanks, including these organisations:

• Stemgent
• Biopta
• BioServe
• Coriell Institute for Medical Research
• Cord Blood America
• Cryo-Cell International.

And other companies, including these:

• China Cord Blood Corp
• LifebankUSA
• ViaCord
• Cord Blood Registry
• Biogenea Pharmaceuticals
• StemLife
• NeoStem.

You assess competitors in that field. You also get interviews with two organisations - 3C-R and UK ME/CFS Biobank. So avoid missing out in knowledge. See what other authorities do, say and think, helping your work.

Ways Biobanking for Medicine: Technology, Industry and Market 2015-2025 helps
In these five main ways, our new investigation helps you get recognition for insight, saving time and benefiting your authority:

• Revenues for biobanking, to 2025, at world level and for 9 submarkets - explore prospects for design, production, sales, marketing, demand and spending
• Forecasts, to 2025, for 12 countries in the Americas, Europe and Asia - assess developed and developing national markets for demand and predicted revenues
• Prospects for established organisations, rising companies and new entrants - examine service and product portfolios, results, strategies and outlooks for success
• Analysis of what stimulates and restrains that industry's participants - investigate challenges, strengths and competition affecting organisations' results
• Interviews with experts - discover what other authorities on that field think, say and do, helping you stay ahead in technological, medical and commercial knowledge.

That report, by visiongain's UK-based analysts, gives knowledge to benefit your research, analyses, plans, decisions and proposals. You get data leading companies depend on.

Information there found nowhere else, helping your searches, analyses and planning
An off-the-shelf report can't answer every question, though our work explains that industry's structures, outlooks and potentials. That's our purpose, helping you stay ahead.

And our analyses give independent data. There you get competitive intelligence found only in that study, finding where progress, money and opportunities lie. See what the future holds.

With that research and analysis you're less likely to fall behind in knowledge or miss opportunity. There see how you could save time and effort. And benefit your plans, decisions and presentations, helping you gain competitive advantages and recognition.

Trying our study now lets you discover biobanking opportunities and predictions
Stay ahead in data. Our new investigation is for everyone analysing medical biotechnology and pharmaceutical R&D. For storing those biological samples you see trends, opportunities and revenue prospects. So avoid missing out - please get that report here now.

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

To request an exec summary of this report please email Sara Peerun at sara.peerun@visiongainglobal.com or call Tel: +44(0)20-7336-6100

Or click on https://goo.gl/Dis6uw

Companies and Other Organisations in the Study
3C-R    
Abbott Laboratories
Accelrys
Adnexus Therapeutics
Advanced Innovative Medicine
AIS
AKH Biobank
AllCells
Allied Minds
AlloSource    
American Association of Tissue Banks
American CryoStem
American Type Culture Collection (ATCC)
Amgen
Analytical Biological Services
ARUP Laboratories
ASPREE Healthy Ageing Biobank
AssureImmune
AstraZeneca
Aurora Biomed
Australian Biospecimen Network (ABN)
Autoscribe Informatics
AuxoCell Laboratories
AXM Shenyang
Bangalore Brain Bank
Barts Gynae Tissue Bank
Bavarian Red Cross (BRK)
Bayer
BBMRI
Beckman Coulter
BINDER
Biobank Ireland Trust
BioFortis
Biogen Idec
Biogenea
Biogenea Pharmaceuticals
BioLife Solutions
Biomatrica
Biomedical Research Council (BMRC)
Biopta
BioRep
BioRepository Resources
BioStorage Technologies
Biovault Technical
Bluechiip Ltd.
BrainNet Europe
Bristol-Myers Squibb
Brooks
Brooks Life Science Systems
Cambridge Biomedical Research Centre
Cambridge Biosciences
Canadian Partnership for Tomorrow
Cancer Genetics Inc
Cancer Genetics India
Cancer Human Biobank (caHUB)
CCLG Tissue Bank
Celgene
Cells4Life
Celltex Therapeutics
Cellular Dynamics
Centro Nazionale per le Risorse Biologiche (CNRB)
Chernobyl Tissue Bank
China Cord Blood Corp.
China Kadoorie Biobank
China Stem Cells
CLB/Amsterdam Medical Center
CMD Biobank
CONCOR
CorCell
Cord Blood Registry (CBR)
CordBlood America
CordLife
CordVida
CORE Informatics
Coriell Institute for Medical Research
Council of Europe (CoE)
Covance
Cryo Bio System
Cryo Save
Cryo-Cell International
Cryogene Lab
CryoLogic
Cryopraxis
CryoXtract Instruments
Cureline
Custom Biogenic Systems
Cybrdi
Daifuku
Danubian Biobank Consortium
deCODE Genetics
Department of Health and Scottish Government
Eli Lilly
EMA
Eppendorf
Esco
European Commission (EC)
European Health Risk Monitoring (EHRM)
European Research Infrastructure Consortium (ERIC)
European Union Group on Ethics (EGE)
FDA
Fisher BioServices
FluidX
Future Health Biobank
GC Biotech
GE Healthcare
GE Healthcare SeqWright Genomic Services
Genentech
GenVault
Gilson
GlaxoSmithKline
Hamilton
Hamilton Robotics
Hamilton Storage Technologies
Harvard Stem Cell Institute
Hospital Necker Paris
Hudson Robotics
Human Science Research Resource Bank (HSRRB)
Human Tissue Bank
Hungarian Biobank
Huntington Disease Biobank
ILSBio
Imperial Tissue Bank
Inbiomed
Indian Institute of Technology
Indivumed
Infectious Disease Biobank
INSERM
Instituto de Salud Carlos III (ISCIII)
IntegenX
International Agency for Research on Cancer (IARC)
International Organization for Standardization
International Society for Biological and Environmental Repositories (ISBER)
International Stem Cell Corporation
Japan Health Sciences Foundation
Kaiser Permanente
King's College London Tissue Bank
KORAgen
Labtech
LABVANTAGE
Labware
LBD Life Sciences
Leiden Longevity
Leiden University Medical Center
LifeBank USA
LifeGene
LifeLines Biobank
Malmo Microbiology Biobank
MatriCal Biosciences
Medical Research Council
Merck
Micronic
Ministry of Health and Welfare
Mitochondrial Disease Biobank
MSD
Narayana Hrudayalaya Tissue Bank and Stem Cell Research Center
National Cancer Institute (NCI)
NeoStem
NESDA
Netherlands Twin Registry
NHS Blood and Transplant Cord Blood Bank
Northwest Regional Development Agency
Novare Biologistics
Novartis
Office of Biorepositories and Biospecimen Research (OBBR)
OnCore UK
Organisation for Economic Co-operation and Development (OECD)
OriGene
Pacific BioStorage
PALGA
Panasonic Biomedical
Parelsnoer
Perkin Elmer
Pfizer
Pharma Cells
Pop-Gen National Cohort
Precious Cells
Precision Bioservices
PrecisionMed
PREVEND
Progenicyte
Progenitor Cell Therapy (PCT)
ProMedDx
Promega
ProteoGenex
Provia Labs
Qiagen
RAND
ReproCELL Group
Riken BRC Cell Bank
Roche
Rotterdam Study
RTS Life Sciences
Russian Society of Personalised Medicine (RSPM)
Sapien Biosciences
Sceil
Seattle Genetics
Sechenov First Moscow Medical University (SFMMU)
Singapore Biobank (SBB)
Singapore Cord Blood Bank
Singapore Tissue Network (STN)
Smart Cells
Spanish Ministry of Science and Innovation (MICINN)
Spanish National Biobank Network
Stanford Tissue Bank
StarLIMS
Steelgate
Stellacure
Stem Cells for Safer Medicine
Stemcyte
Stemgent
StemLife
StemSave
Swedish Institute for Infectious Disease Control Biobank
System Biosciences
Taiyo Nippon Sanso
TAP Biosystems
Tata Memorial Hospital Tissue Bank
TCG Life Sciences Tissue Bank
Tecan
The Cambridge Brain Bank
The Guangzhou Biobank
The National Cancer Tissue Bank
Thermo Genesis
Thermo Scientific
Tissue Solutions
Titan Pharmaceuticals
TTP Labtech
UCL Biobank
UK Biobank
UK ME-CFS Biobank
UK Multiple Sclerosis Tissue Bank
UK Parkinson's Disease Tissue Bank
UK Stem Cell Bank
University of Tuebingen
US Biomax
US Department of Transportation's (DOT's)
V.A. Almazov Federal Center for Heart, Blood and Endocrinology
ViaCord
VidaPlus
Virgin Health Bank
Wellcome Trust
Wheaton
Wisconsin International Stem Cell (WISC) Bank
World Health Organization (WHO)
Wyeth

To request an exec summary of this report please email Sara Peerun at sara.peerun@visiongainglobal.com or call Tel: +44(0)20-7336-6100

Or click on https://goo.gl/Dis6uw

SOURCE Visiongain